Achieved an unprecedented 98% patient retention rate across a complex 18-month Phase III oncology trial involving 150 patients at Brigham and Women's Hospital, a crucial factor in maintaining statistical power and ensuring timely data lock for the Clinical Research Coordinator role. This success was driven by proactive patient engagement strategies and comprehensive support systems, overcoming the significant challenge of long-term commitment often seen in demanding cancer treatment protocols. My ability to build rapport and effectively communicate complex study details directly contributed to this high adherence, preventing costly delays and ensuring robust data integrity.
My experience encompasses a full spectrum of clinical trial operations, consistently delivering high-quality results. I successfully managed all regulatory submissions for five concurrent new studies, ensuring 100% compliance with FDA and ICH GCP guidelines, which prevented any IRB approval delays. Utilizing Medidata Rave, I streamlined Electronic Data Capture (EDC) for a multi-site cardiovascular study, cutting query resolution time by 30% through targeted data entry training. Furthermore, I developed and implemented targeted recruitment strategies, increasing enrollment by 25% for a rare neurological disease trial, overcoming significant patient identification challenges.
Innovate Clinical Solutions' dedication to advancing novel oncology therapies aligns perfectly with my commitment to improving patient outcomes through meticulous research. Your recent initiatives in leveraging adaptive trial designs, as highlighted in your white paper on accelerated drug development, particularly resonate with my expertise in optimizing trial efficiency and maintaining rigorous regulatory standards. My strengths in both patient advocacy and complex data management would directly support your mission to bring life-changing treatments to patients faster, ensuring both compassion and compliance are at the forefront.
My robust background in clinical research coordination, particularly within demanding therapeutic areas and complex multi-site environments, positions me to make immediate and significant contributions to your team. I am confident my comprehensive understanding of GCP/ICH guidelines, coupled with a proactive approach to patient care and data integrity, will be invaluable to Innovate Clinical Solutions. I welcome the opportunity to discuss how my qualifications align with your objectives and contribute to the success of your upcoming clinical trials.
Best regards,
Brandon Jackson